Teresa Amaral, Vice-Chair of SAG Oncology at the European Medicines Agency, Head of Early Phase Clinical Trials, Skin Cancer and Sarcoma Program at Institute Strauss, shared a post by EORTC – European Organisation for Research and Treatment of Cancer, on LinkedIn, adding:
”We are on the last day of this fantastic work shop, and it has been, as always, a magnificent experience!
Excellent science, fantastic colleagues, brilliant fellows, and a shared will to bring academic research to the front line when it comes to changing the paradigms and improving patients’ lives!
The opportunity to interact with such bright minds and receive 1st-hand feedback from patient advocates is priceless.
The MCCR2026 edition is now over…(family photo below!), but if you have a protocol idea you want to battle-proof before submission, this is your opportunity!
Don’t forget to apply. In fact, some practice changing protocols were initially discussed here, in this high-level environment. Congratulations to all who made it here this year. It was great to know you all and to serve yet another year as faculty!
Special thanks to my PDG8 faculty Marco Donia, Lillian Siu, and the fabulous statistician Tao Wang!”
Quoting EORTC – European Organisation for Research and Treatment of Cancer‘s post:
”MCCR Workshop Class of 2026.
An inspiring week bringing together dedicated fellows and generous faculty – sharing ideas and building connections that outlast the workshop.
Since 1999, MCCR has been a space where protocols take shape, careers grow, and clinical cancer research moves forward.”
Other Articles Featuring Teresa Amaral And EORTC on OncoDaily.